W. M. Potts

Activation of the oncogenic potential of the avian cellular src protein by specific structural alteration of the carboxy terminus.

Albert B. Reynolds, Jordi Vilà, Timothy J. Lansing et al. · The EMBO Journal · 1987 · 179 citations · Full text

Medicine, Cancer Biology, Molecular Biology +9

Nonpeptide Tachykinin Receptor Antagonists: I. Pharmacological and Pharmacokinetic Characterization of SB 223412, a Novel, Potent and Selective Neurokinin-3 Receptor Antagonist

Henry M. Sarau, Don E. Griswold, W. M. Potts et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 107 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +10

Nonpeptide Tachykinin Receptor Antagonists. III. SB 235375, a Low Central Nervous System-Penetrant, Potent and Selective Neurokinin-3 Receptor Antagonist, Inhibits Citric Acid-Induced Cough and Airways Hyper-reactivity in Guinea Pigs

Douglas W.P. Hay, Giuseppe Giardina, Don E. Griswold et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 90 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

[11C]AZ10419369: A selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain

M. Edward Pierson, Jan Andersson, Svante Nyberg et al. · NeuroImage · 2008 · 88 citations

Medicine, Neuroscience, Pharmacology +16

Activation of pp60c-src transforming potential by mutations altering the structure of an amino terminal domain containing residues 90-95.

W. M. Potts, A B Reynolds, Timothy J. Lansing et al. · PubMed · 1988 · 86 citations

Life Sciences, Biochemistry, Molecular Biology +14